“First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results”, Swiss Med Wkly, vol. 148, no. 0708, p. w14593, Feb. 2018, doi: 10.4414/smw.2018.14593.